Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
CREATE Medicines
organization2 mentionslast seen Nov 6, 2026
Clinical-stage biotechnology company pioneering in vivo multi-immune programming.
Relationships 9
- CREATE MedicinesdevelopsCRT-40299% confidence2 sources
- CREATE Medicinesdevelopsin vivo CAR-T therapy99% confidence2 sources
- CREATE MedicinesemploysDaniel Getts99% confidence2 sources
- CREATE MedicinesemploysAdam Raff98% confidence1 source
- CREATE MedicinesemploysMatthew Maurer96% confidence1 source
- CREATE MedicinesdevelopsMT-30393% confidence1 source
- CREATE MedicinesdevelopsMT-30293% confidence1 source
- CREATE MedicinesdevelopsMT-30493% confidence1 source
- CREATE Medicinesdepends onmRNA-LNP platform90% confidence1 source
Relationship
CREATE Medicinesdevelopsin vivo CAR-T therapy
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireNov 6, 2026CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London
CREATE Medicines is a clinical-stage biotech pioneering in vivo CAR therapy
- newsPR NewswireOct 27, 2026CREATE Medicines to Host Pre-Congress Workshop and Present on In Vivo CAR-T for Autoimmune Disease at APLAR 2026
CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo multi-immune programming